Kenneth Pham

Kenneth Pham

Auto-generated profile, based on publicly available information

Kenneth Pham

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CZChaogu Zheng
Chaogu Zheng
HLHo Ming Terence Lee
Ho Ming Terence Lee
KPKenneth Pham
Kenneth Pham
Hox genes encode evolutionarily conserved transcription factors that specify regional identities along the anterior-posterior (A-P) axis. Although some Hox genes are known to regulate the differentiation of certain neurons, to what extent Hox genes are involved in the terminal specification of the entire nervous system is unclear. Here, we systematically mapped the expression of all six Hox genes in C. elegans nervous system and found Hox expression in 97 (32%) of the 302 neurons in adult hermaphrodites. Our results are generally consistent with previous high-throughput expression mapping and single-cell transcriptomic studies. Detailed analysis of the fate markers for these neurons revealed that Hox genes regulate the differentiation of 29 (25%) of the 118 classes of C. elegans neurons. Hox genes not only regulate the specification of terminal neuronal fates through multiple mechanisms but also control subtype diversification along the A-P axis. The widespread involvement of Hox genes in neuronal differentiation indicates their roles in establishing complex nervous systems.

12 May 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
RPRohan Patel
Rohan Patel
KPKenneth Pham
Kenneth Pham
HCHarshini Chandrashekar
Harshini Chandrashekar
JPJennifer E. Phillips-Cremins
Jennifer E. Phillips-Cremins
Sequential Oligopaints DNA FISH is an imaging technique that measures higher-order genome folding at single-allele resolution via multiplexed, probe-based tracing. Currently there is a paucity of algorithms to identify 3D genome features in sequential Oligopaints data. Here, we present FISHnet, a graph theory method based on optimization of network modularity to detect chromatin domains in pairwise distance matrices. FISHnet sensitively and specifically identifies domains and boundaries in both simulated and real single-allele imaging data and provides statistical tests for the identification of cell-type-specific domains-like folding patterns. Application of FISHnet across multiple published Oligopaints datasets confirms that nested domains consistent with TADs and subTADs are not an emergent property of ensemble Hi-C data but also observable on single alleles. We make FISHnet code freely available to the scientific community, thus enabling future studies aiming to elucidate the role of single-allele folding variation on genome function.

16 September 2025 in Ophthalmology
Verified
Journal Article
Open access
KPKenneth Pham
Kenneth Pham
RSRebecca Salowe
Rebecca Salowe
IRIsabel Di Rosa
Isabel Di Rosa
AHAli G. Hamedani
Ali G. Hamedani
GYGui-Shuang Ying
Gui-Shuang Ying
Joan O'BrienJoan O'Brien
Joan O'Brien
To assess the association between glaucoma and its subtypes and incidence of dementia and its subtypes across APOE genotypes in the National Institutes of Health (NIH) All of Us Research Program. Retrospective, longitudinal cohort study. A cohort of individuals with linked electronic health record (EHR) data in the All of Us dataset, with every individual with a glaucoma diagnosis matched with four control participants. Participants diagnosed with dementia before glaucoma were excluded. A 1:4 cohort of participants with glaucoma and control participants was created using a propensity score-matching design that considered age, race, ethnicity, and sex. Participants with whole-genome sequencing data were stratified by APOE genotype for sub-analyses. A multivariable Cox regression model was used to adjust for residual imbalance in comorbidities. Incidence of dementia and its subtypes. Among the 393 497 All of Us participants with linked EHRs, we identified 9444 individuals (2.40%) with glaucoma diagnoses (excluding participants with diagnoses of dementia before glaucoma) and 37 776 matched controls without glaucoma. During the observation period (median, 6.5 years; interquartile range, 3.3-10.7 years), dementia was diagnosed in 1127 individuals (2.39%). Glaucoma was associated with a significantly increased risk of all-cause dementia (adjusted hazard ratio [aHR], 1.23; 95% confidence interval [CI], 1.08-1.40), Alzheimer's disease (aHR, 1.60; 95% CI, 1.26-2.02), and vascular dementia (aHR, 1.38; 95% CI, 1.04-1.83). Among glaucoma subtypes, primary open-angle glaucoma (POAG, N = 5756) and normal-tension glaucoma (NTG, N = 1106) were linked to an elevated risk of Alzheimer's disease (POAG: aHR, 1.48, 95% CI, 1.11-1.96; NTG: aHR, 1.87, 95% CI, 1.09-3.18), whereas angle-closure glaucoma (N = 3150) showed no significant association (aHR, 1.49; 95% CI, 0.91-2.27). Glaucoma was associated with an increased risk of all-cause dementia across the three APOE genotypes assessed, (ε2ε3 > ε3ε3 > ε3ε4). Glaucoma was associated with a higher risk of dementia across APOE genotypes, with varying associations among glaucoma and dementia subtypes. The author(s) have no proprietary or commercial interest in any materials discussed in this article.

30 September 2025 in bioRxiv
Verified
Preprint
Open access
PXPeibo Xu
Peibo Xu
KCKeerthivasan Raanin Chandradoss
Keerthivasan Raanin Chandradoss
BLBradley Lukasak
Bradley Lukasak
APAlekh Paranjapye
Alekh Paranjapye
AWAbraham J. Waldman
Abraham J. Waldman
JPJennifer E. Phillips-Cremins
Jennifer E. Phillips-Cremins
Long-term memories are stored in neuronal ensembles called engrams, but the existence of persistent molecular traces in nuclei of engram neurons remain unknown. Using activity-dependent nuclear tagging in vivo , we profiled higher-order chromatin folding and DNA methylation in thousands of single hippocampal neurons up to a month after contextual fear conditioning (CFC). We find CFC-induced chromatin loop plasticity genome-wide, including persistently gained and lost loops with enduring traces in vivo . DNA methylation showed minimal CFC-induced persistence at promoters and enhancers. Persistently gained and lost loops connect distinct enhancers and promoters in excitatory and inhibitory subtypes and correlate with robust CFC-upregulated and -downregulated gene expression, respectively, upon recall. Synaptic genes associated with post-traumatic stress disorder and autism anchor neuronal subtype-specific persistent loops, suggesting relevance to neuropsychiatric dysfunction. We harness the power and sensitivity of multi-modal single-cell measurements to find enduring chromatin traces linked to robust gene expression during fear memory recall. Structured Introduction: Long-term memory is thought to be stored in specific neural circuits called engrams ( 1 ). Mechanisms centered at the synapse have been proposed, but what is altered within each engram cell that persists for the duration of the memory is unknown. Neural circuits fire action potentials in response to experiences. Such electrochemical signals are converted to molecular signaling pathways which travel from the synapse to the nucleus to activate new gene expression programs. However, experience-dependent RNA and protein molecules as well as synaptic plasticity phenomena are short-lived, lasting for only a few hours to several days ( 2 ). Thus, the extent to which chromatin and gene expression changes induced by behavior persist and functionally contribute to memory encoding, consolidation, and retrieval remains an important answered question. DNA is folded in the mammalian nucleus into higher-order long-range chromatin looping interactions ( 3 ). Loops form mechanistically through extrusion in which cohesin subunits form a ring that shuttles along chromatin and extrudes out the intervening DNA until it stalls at boundaries occupied by architectural proteins such as CTCF ( 4, 5 ). CTCF-independent looping mechanisms have also been uncovered ( 6–10 ). A subset of loops regulates gene expression by bringing distant enhancers into spatial proximity with their target promoters. Loops connect activity-dependent enhancers to their distal target genes to govern gene expression during in vitro neural stimulation and in vivo behavior paradigms ( 11–14 ). However, the extent to which chromatin changes persist on time scales to support long-term memory storage in vivo remains unclear. Rationale: Multiple studies support the idea that higher-order chromatin architecture is plastic and can undergo activity- and experience-dependent remodeling linked to gene expression. Electron microscopy measurements provide direct evidence of chromatin architecture plasticity within minutes, with some changes persisting for up to an hour after potassium chloride stimulation of primary hippocampal neurons ( 15 ). Perturbing loops by selectively eliminating either CTCF or cohesin subunits impairs memory encoding in multiple behavior models ( 11, 14, 16–18 ), disrupts long-term potentiation ( 17, 18 ), and alters dendritic morphology ( 13, 19, 20 ). Cohesin-mediated loops are necessary for the establishment of new gene expression programs in post-mitotic neurons, including the upregulation of genes encoding axon guidance, dendritic spine morphology, and synaptic plasticity during neuron maturation in vivo as well as activity-dependent regulation of secondary response genes during neural stimulation in vitro ( 12, 13 ). The state of histone modifications before learning influences which neurons are recruited into memory traces, suggesting chromatin carries long-lasting yet adaptable information during memory encoding and long-term storage ( 21 ). Moreover, a subset of enhancers retains chromatin accessibility after learning in vivo ( 11 ). Together, these observations suggest that chromatin might provide a durable regulatory scaffold that persists long after the initial experience to govern gene expression programs required for the aspects of long-term memory storage. Results: Here, we employ activity-dependent nuclear labeling in TRAP2 (targeted recombination in active populations) mice to isolate nuclei from neurons stimulated during contextual fear conditioning (CFC) ( 22, 23 ). Using single-nucleus methyl 3C-sequencing (snm3C-seq3), we simultaneously profiled DNA methylation and 3D genome folding in the same single tagged neurons from the hippocampus in a time course up to 28 days after CFC and during fear memory recall. Our multi-modal inquiry offered ability to group neurons by their neuronal subtype-specific DNA methylation profile, and thereby computationally generate pseudobulk Chromosome Conformation Capture heatmaps per each sorted hippocampal neuron subtype. We find CFC-induced chromatin loop plasticity genome-wide, including persistently gained and persistently lost loops with enduring structural traces up to 28 days after training. Persistent loops connect distinct distal enhancers to target genes encoding synaptic plasticity and neurotransmitter signaling pathways unique to each excitatory and inhibitory neuron cell type. By contrast to loops, we observe negligible persistence of CFC-induced changes in DNA methylation at enhancers and promoters. Persistently gained and lost loops show upregulation and downregulation of gene expression upon recall, respectively, with the functional effect focused on genes with mRNA levels influenced during training. We uncovered a strong enrichment for genes associated with post-traumatic stress disorder and autism spectrum disorder anchoring the base of persistent loops, suggesting the relevance of enduring chromatin architecture traces to dysregulation of fear, anxiety, and stress in neuropsychiatric disorders. Conclusion: Our findings reveal that learning induces neuronal subtype-specific changes in chromatin loops, a subset of which remain durable for at least a month in vivo . Persistent chromatin loops are linked to expression of disease-associated synaptic genes during fear memory recall, thus highlighting relevance to neuropsychiatric and neurodevelopmental disorders. Our work opens up new avenues for investigating enduring chromatin traces for their role in governing cell-wide mRNA levels of genes that impact synaptic plasticity during fear learning and long-term memory storage.

21 June 2025 in Ophthalmology
Verified
Journal Article
Open access
KPKenneth Pham
Kenneth Pham
FJFangming Jin
Fangming Jin
RLRoy Lee
Roy Lee
IRIsabel Di Rosa
Isabel Di Rosa
RSRebecca Salowe
Rebecca Salowe
Joan O'BrienJoan O'Brien
Joan O'Brien
To assess the association between the systemic use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) and primary open-angle glaucoma (POAG). Retrospective cohort study. Individuals aged ≥40 years with linked electronic health record (EHR) data in the National Institutes of Health (NIH) All of Us dataset. Participants with a diagnosis of POAG before the use of NRTIs were excluded. A cohort of 1:10 NRTI users to nonusers was created using a propensity score matching design, considering age, race, sex at birth, human immunodeficiency virus (HIV) diagnosis, hepatitis B diagnosis, and family history of POAG. A multivariable logistic regression model was used to adjust for residual imbalance. Sensitivity analyses were performed for self-reported eye doctor visits. Diagnosis of POAG. Among the 305 441 All of Us participants aged ≥40 years with a linked EHR, we identified 718 individuals (0.24%) with NRTI use, excluding participants with a diagnosis of POAG before NRTI exposure. The rate of POAG in the NRTI users was 4.32% (N = 31). The rate of POAG in the propensity score-matched control group (N = 7180) was 2.00% (N = 144). Use of NRTI was associated with an increased risk of POAG (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.48-3.28; P < 0.001). When adjusting for residual imbalance of family history of POAG, HIV diagnosis, and hepatitis B diagnosis, use of any NRTIs remained significantly associated with an increased risk of developing POAG (OR, 1.84; 95% CI, 1.22-2.77; P = 0.004). After matching and adjusting for self-reported eye doctor visits, NRTIs remained significantly associated with POAG risk (OR, 2.30; 95% CI, 1.07-4.96; P = 0.033). Use of NRTIs was associated with a higher risk of POAG with propensity score matching for covariates and adjusting for residual imbalances. The author(s) have no proprietary or commercial interest in any materials discussed in this article.

19 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KPKenneth Pham
Kenneth Pham
TMThomas Malachowski
Thomas Malachowski
LZLinda Zhou
Linda Zhou
JKJi Hun Kim
Ji Hun Kim
CSChuanbin Su
Chuanbin Su
JPJennifer E. Phillips-Cremins
Jennifer E. Phillips-Cremins
Diseases vary in clinical presentation across individuals despite the same molecular diagnosis. In fragile X syndrome (FXS), mutation-length expansion of a CGG short tandem repeat (STR) in FMR1 causes reduced gene expression and FMRP loss. Nevertheless, FMR1 and FMRP are limited predictors of adaptive functioning and cognition in FXS patients, suggesting that molecular correlates of clinical measures would add diagnostic value. We recently uncovered Megabase-scale domains of heterochromatin (BREACHes) in FXS patient-derived iPSCs. Here, we identify BREACHes in FXS brain tissue (N=4) and absent from sex/age-matched neurotypical controls (N=4). BREACHes span >250 genes and exhibit patient-specific H3K9me3 variation. Using N=4 FXS iPSC lines and N=7 single-cell isogenic FXS iPSC subclones, we observe a strong correlation between inter-sample H3K9me3 variation and heterogeneous BREACH gene repression. We demonstrate improved prediction of cognitive metrics in FXS patients with an additive model of blood FMRP and mRNA levels of H3K9me3-mosaic, but not H3K9me3-invariant, BREACH genes. Our results highlight the utility of H3K9me3 variation at BREACHes for identifying genes associated with FXS clinical metrics.